Tone Bjørge er professor i epidemiologi ved Institutt for globale helse og samfunnsmedisin ved Universitetet i Bergen. Hennes forskningsfelt er kreftepidemiologi. Les mer på https://www.uib.no/en/persons/Tone.Bjørge. 

• Underviser på kurs i epidemiologi for master og PhD studenter
• Veileder medisinstudenter (hovedoppgave), PhD studenter og postdoktorer

2026

• Dagrun Slettebø Daltveit ; Kari Klungsøyr; Anders Engeland et al. (2026). Preterm birth, major birth defects and childhood cancer risk: a large Scandinavian population-based case-control study. (ekstern lenke)

2025

• Mohsen Naghavi; Hmwe Hmwe Kyu; Bhoomadevi A et al. (2025). Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. (ekstern lenke)
• Benjamin A Stark; Nicole K DeCleene; Emily C Desai et al. (2025). Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. (ekstern lenke)
• Lisa M. Force; Jonathan M. Kocarnik; Miranda L. May et al. (2025). The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. (ekstern lenke)
• Rachel Bedenis Forster; Camilla Kjellstadli; Rupali Rajendra Akerkar et al. (2025). Association Between Prostate Cancer and Myocardial Infarction Management and Postinfarction Outcomes: A Norwegian Registry Study. (ekstern lenke)
• Ingrid Baasland; Tone Bjørge; Birgit Øvstebø Engesæter et al. (2025). Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment. (ekstern lenke)
• Sarah M. Baxter; Tone Bjørge; Rolf Bjerkvig et al. (2025). Use of psychotropic medications among glioma patients in Denmark, Norway, Sweden, and Wales. (ekstern lenke)
• GBD 2021 Adult BMI Collaborators; Jessica A Kerr; Karly I Cini et al. (2025). Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. (ekstern lenke)
• Jessica A. Kerr; George C. Patton; Karly I. Cini et al. (2025). Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. (ekstern lenke)
• Tone Bjørge; Nathalie Charlotte Støer; Sara Kristine Kildal Hverven et al. (2025). Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study. (ekstern lenke)
• Nicholas Steel; Clarissa Maria Mercedes Bauer-Staeb; Bauer-Staeb Clarissa Maria Mercedes et al. (2025). Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. (ekstern lenke)

2015

• Anders Engeland; Tone Bjørge; Kari Klungsøyr et al. (2015). Preeclampsia in pregnancy and later use of antihypertensive drugs. (ekstern lenke)
• Tor Haldorsen; Gry Baadstrand Skare; Giske Ursin et al. (2015). Results of delayed triage by HPV testing and cytology in the Norwegian Cervical Cancer Screening Programme. (ekstern lenke)
• Trude Gildestad; Tone Bjørge; Stein Emil Vollset et al. (2015). Folic acid supplements and risk of oral clefts in the newborn: A population-based study.. (ekstern lenke)
• Jan Helge Seglem Mortensen; Nina Øyen; Tatiana Fomina et al. (2015). Supplemental folic acid in pregnancy and maternal cancer risk. (ekstern lenke)
• Tanja Stocks; Tone Bjørge; Hanno Ulmer et al. (2015). Metabolic risk score and cancer risk: pooled analysis of seven cohorts. (ekstern lenke)

2000

• T. Bjørge; Anne Dørum; Claes Gøran Trope (2000). Ovarialcancerscreening. (ekstern lenke)
• Pentti Koskela; Tarja Anttila; T. Bjørge et al. (2000). Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. (ekstern lenke)
• P Koskela; T Antilla; T Bjørge et al. (2000). Chlamydia trachomatis infection as a risk factor for invasive cervical carcinoma. (ekstern lenke)
• Tapio Luostarinen; Matti Lehtinen; T. Bjørge et al. (2000). The joint effects of sexually transmitted infections on the risk of cervical cancer. (ekstern lenke)

2005

• Tone Bjørge; Steinar Tretli; Anders Engeland (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. (ekstern lenke)
• Tone Bjørge; Steinar Tretli; Anders Engeland (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. (ekstern lenke)
• Anders Engeland; Steinar Tretli; G Austad et al. (2005). Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. (ekstern lenke)
• Synne Knopp; Tone Bjørge; Jahn M Nesland et al. (2005). Cyclins D1, D3, E, and A in vulvar carcinoma patients. (ekstern lenke)

2011

• Michael Edlinger; Tone Bjørge; Jonas Manjer et al. (2011). METABOLIC SYNDROME AND RISK OF BRAIN TUMOUR IN A LARGE POPULATION-BASED COHORT STUDY. (ekstern lenke)
• G Nagel; Tone Bjørge; H Concin et al. (2011). METABOLIC SYNDROME AND CERVICAL CANCER IN THE METABOLIC SYNDROME AND CANCER PROJECT (ME-CAN). (ekstern lenke)
• Martin Almquist; Dorthe Johansen; Tone Bjørge et al. (2011). Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). (ekstern lenke)
• Tone Bjørge; Annekatrin Lukanova; Steinar Tretli et al. (2011). Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. (ekstern lenke)
• Tor Haldorsen; Gry Baadstrand Skare; Tone Bjørge et al. (2011). HPV-evaluering: Ekstra celleprøve kompenserer ikke for lav sensitivitet på den norske testen. (ekstern lenke)
• Tor Haldorsen; Gry Baadstrand Skare; Tone Bjørge et al. (2011). HPV-evalueringen: Ingen særbehandling av enkelttester. (ekstern lenke)
• Bente Kristin Johansen; Tone Bjørge (2011). Special Issue: Cancer Screening in Norway, 2011. (ekstern lenke)
• Gabriele Nagel; Hans Concin; Tone Bjørge et al. (2011). Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). (ekstern lenke)
• Anders Engeland; Tone Bjørge; Anne Kjersti Daltveit et al. (2011). Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. (ekstern lenke)
• Tone Bjørge (2011). Årsrapport for Medisinsk fødselsregister 2009. Fødsler i Norge. (ekstern lenke)
• S Strohmaier; Tone Bjørge; J Manjer et al. (2011). TOTAL SERUM CHOLESTEROL AND CANCER INCIDENCE IN THE METABOLIC SYNDROME AND CANCER PROJECT (ME-CAN). (ekstern lenke)
• Tor Haldorsen; Gry Baastrand Skare; Tone Bjørge (2011). Sekundærscreening med HPV-tester i Masseundersøkelsen mot livmorhalskreft. (ekstern lenke)
• Karen Klepsland Mauland; Jone Trovik; Elisabeth Wik et al. (2011). High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. (ekstern lenke)
• Marte Gravseth Espnes; Tone Bjørge; Anders Engeland (2011). Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. (ekstern lenke)
• Stefan De Vogel; Jörn Schneede; Per Magne Ueland et al. (2011). Biomarkers related to one-carbon metabolism as potential risk factors for distal colorectal adenomas. (ekstern lenke)
• Christel Häggström; Tanja Stocks; Kilian Rapp et al. (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). (ekstern lenke)
• Jorunn Kirkeleit; Trond Riise; Tone Bjørge et al. (2011). The Strength of the Healthy Worker Effect Varies According to the Type of Cancer Being Studied. (ekstern lenke)
• Tanja Stocks; Annekatrin Lukanova; Tone Bjørge et al. (2011). Metabolic Factors and the Risk of Colorectal Cancer in 580,000 Men and Women in the Metabolic Syndrome and Cancer Project (Me-Can). (ekstern lenke)
• Anne Tandberg; Kari Klungsøyr Melve; Tone Irene Nordtveit et al. (2011). Maternal birth characteristics and perinatal mortality in twin offspring. An intergenerational population-based study in Norway, 1967-2008. (ekstern lenke)
• Wegene Borena; Tanja Stocks; Håkan Jonsson et al. (2011). Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. (ekstern lenke)
• Tone Bjørge (2011). Årstabeller for Medisinsk fødselsregister 2009. Fødsler i Norge. (ekstern lenke)

2018

• Ruth C Travis; Aurora Perez-Cornago; Paul N Appleby et al. (2018). A collaborative analysis of individual participant data from 19 prospective studies assesses circulating Vitamin D and prostate cancer risk. (ekstern lenke)
• Hmwe Hmwe Kyu; Degu Abate; Kalkidan Hassen Abate et al. (2018). Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.. (ekstern lenke)
• Anders Engeland; Tone Bjørge; Kari Klungsøyr et al. (2018). Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. (ekstern lenke)
• Jorunn Kirkeleit; Trond Riise; Tone Bjørge et al. (2018). Maternal exposure to gasoline and exhaust increases the risk of childhood leukaemia in offspring - a prospective study in the Norwegian Mother and Child Cohort Study. (ekstern lenke)
• Stanley Teleka; Christel Häggström; Gabriele Nagel et al. (2018). Risk of bladder cancer by disease severity in relation to metabolic factors and smoking: A prospective pooled cohort study of 800,000 men and women. (ekstern lenke)
• Camilla Sköld; Tone Bjørge; Anders Ekbom et al. (2018). Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. (ekstern lenke)
• Rebecca Troisi; Anne Gulbech Ording; Tom Grotmol et al. (2018). Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. (ekstern lenke)
• JD Stanaway; A Afshin; E Gakidou et al. (2018). Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.. (ekstern lenke)
• Rebecca Troisi; Tone Bjørge; Mika Gissler et al. (2018). The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence. (ekstern lenke)
• Olav Karsten Vintermyr; Marie Songstad Andersland; Tone Bjørge et al. (2018). Human papillomavirus type specific risk of progression and remission during long-term follow-up of equivocal and low-grade HPV-positive cervical smears. (ekstern lenke)
• Max G Griswold; Nancy Fullman; Caitlin Hawley et al. (2018). Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. (ekstern lenke)
• Jan Helge Seglem Mortensen; Nina Øyen; Roy Miodini Nilsen et al. (2018). Paternal characteristics associated with maternal periconceptional use of folic acid supplementation. (ekstern lenke)

2001

• agnes kathrine lie; tone bjørge; å helland et al. (2001). kan testing og vaksinering for humant papillomavirus forebygge livmorhalskreft. (ekstern lenke)
• A. Kathrine Lie; T. Bjørge; Åslaug Helland et al. (2001). Kan testing og vaksinering av humant papillomavirus forebygge livmorhalskreft?. (ekstern lenke)

1997

• T. Bjørge; Anders Engeland; Svein Hansen et al. (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. (ekstern lenke)
• Claes Gøran Trope; T. Bjørge; Anders Engeland et al. (1997). Prognosis of 3,000 Patients with Epithelial Ovarian Cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. (ekstern lenke)
• T. Bjørge; Claes Gøran Trope (1997). Hormonell substitusjonsbehandling og kreft. (ekstern lenke)
• T. Bjørge; Anders Engeland; Claes Gøran Trope (1997). Ovarian Cancer-Are we making progress?. (ekstern lenke)
• T. Bjørge; Anders Engeland; S.W. Hansen et al. (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93. (ekstern lenke)
• T. Bjørge; Joakim Dillner; Tarja Anttila et al. (1997). Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. (ekstern lenke)
• T. Bjørge; Timo Hakulinen; Anders Engeland et al. (1997). A Prospective, Seroepidemiological Study of the Role of Human Papillomavirus in Esophageal Cancer in Norway. (ekstern lenke)
• Joakim Dillner; Matti Lehtinen; T. Bjørge et al. (1997). Prospective seroepidemiologic study of human papilloma virus infection as a risk factor for invasive cervical cancer. (ekstern lenke)

2009

• Jorunn Kirkeleit; Trond Riise; Tone Bjørge et al. (2009). Increased risk of oesophageal adenocarcinoma among upstream petroleum workers. (ekstern lenke)
• Tone Bjørge; Sven Cnattingius; Anders Engeland et al. (2009). Fetal down syndrome and the risk of maternal breast cancer. (ekstern lenke)
• Anders Engeland; Tone Bjørge; Anne Kjersti Nesje Daltveit et al. (2009). Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. (ekstern lenke)
• Tanja Stocks; Kilian Rapp; Tone Bjørge et al. (2009). Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. (ekstern lenke)

2014

• Stefan De Vogel; Arve Ulvik; Klaus Meyer et al. (2014). Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer – a large nested case-control study within the JANUS cohort in Norway. (ekstern lenke)
• Christel Häggström; Tanja Stocks; Gabriele Nagel et al. (2014). Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. (ekstern lenke)
• Wegene Borena; Michael Edlinger; Tone Bjørge et al. (2014). A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. (ekstern lenke)
• Björn Lindkvist; Dorthe Johansen; Tanja Stocks et al. (2014). Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project. (ekstern lenke)
• Mathilde Hjelle Nitter; Benedicte Wentzel Norgård; Stefan De Vogel et al. (2014). Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). (ekstern lenke)
• Sara Wirén; Christel Häggstrøm; Hanno Ulmer et al. (2014). Pooled cohort study on height and risk of cancer and cancer death. (ekstern lenke)

2024

• Ming Sun; Marisa Eleonor da Silva; Tone Bjørge et al. (2024). Body mass index and risk of over 100 cancer forms and subtypes in 4.1 million individuals in Sweden: the Obesity and Disease Development Sweden (ODDS) pooled cohort study. (ekstern lenke)
• Alize J Ferrari; Damian Francesco Santomauro; Amirali  Aali et al. (2024). Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Tor-Arne Hegvik; Yanyan Zhou; Katrin Brauckhoff et al. (2024). Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study. (ekstern lenke)
• Stein Emil Vollset; Hazim S Ababneh; Yohannes Habtegiorgis Abate et al. (2024). Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Birgit Engesæter; Tone Bjørge; Nathalie Charlotte Støer et al. (2024). Effect of the childhood HPV vaccination program in Norway: - HPV prevalence and incidence of cervical intraepithelial neoplasia. (ekstern lenke)
• Sina Rostami; Trine B. Rounge; Luca Pestarino et al. (2024). Differential levels of circulating RNAs prior to endometrial cancer diagnosis. (ekstern lenke)
• Michael Brauer; Gregory A. Roth; Aleksandr Y. Aravkin et al. (2024). Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Mohammad Jalil Sharifian; Jannicke Igland; Kari Klungsøyr et al. (2024). Incidence trends of adult glioma in Norway and its association with occupation and education: A registry-based cohort study. (ekstern lenke)
• Dagrun Slettebø Daltveit; Tone Bjørge; Kari Klungsøyr (2024). Birth defects and cancer risk : Nordic population-based studies of cancer risk in children, adolescents, and adults with major birth defects and their siblings. (ekstern lenke)
• Natalia V. Bhattacharjee; Austin E Schumacher; Amirali Aali et al. (2024). Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Mohsen Naghavi; Kanyin Liane Ong; Amirali Aali et al. (2024). Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Tone Bjørge; Pétur Benedikt Juliusson (2024). Helseregistrene: Dataene er der – men får vi brukt dem?. (ekstern lenke)
• Austin E Schumacher; Hmwe Hmwe Kyu; Amirali  Aali et al. (2024). Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)
• Jaimie D. Steinmetz; Katrin Maria Seeher; Nicoline Schiess et al. (2024). Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. (ekstern lenke)

2016

• Maria Winther Gunnes; Rolv T. Lie; Tone Bjørge et al. (2016). Reproduction and marriage among male survivors of cancer in childhood, adolescence and young adulthood: a national cohort study. (ekstern lenke)
• Tone Bjørge; Mika Gissler; Anne Gulbech Ording et al. (2016). Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. (ekstern lenke)
• Haakon E Meyer; Nathalie Støer; Sven Ove Samuelsen et al. (2016). Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men. (ekstern lenke)
• Alison J. Price; Ruth C. Travis; Paul N. Appleby et al. (2016). Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. (ekstern lenke)
• Maria Winther Gunnes; Rolv T. Lie; Tone Bjørge et al. (2016). Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study. (ekstern lenke)
• Jan Helge Seglem Mortensen; Nina Øyen; Tatiana Fomina et al. (2016). Supplemental folic acid in pregnancy and childhood cancer risk. (ekstern lenke)
• Tone Bjørge; Gry Baadstrand Skare; Line Bjørge et al. (2016). Adverse pregnancy outcomes after treatment for cervical intraepithelial neoplasia. (ekstern lenke)
• Mette Løkeland; Tone Bjørge; Ole-Erik Iversen et al. (2016). Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013. (ekstern lenke)
• Sara Ghaderi; Anders Engeland; Maria Winther Gunnes et al. (2016). Educational attainment among long-term survivors of cancer in childhood and adolescence: a Norwegian population-based cohort study. (ekstern lenke)

2019

• Jeffrey D. Stanaway; Ashkan Afshin; Emmanuela Gakidou et al. (2019). Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1923–1994), (S0140673618322256), (10.1016/S0140-6736(18)32225-6)). (ekstern lenke)
• Jan Helge Seglem Mortensen; Tone Bjørge (2019). Folic acid in pregnancy and subsequent cancer risk in mothers and their children: An epidemiologic study in Norway, 1999–2010. (ekstern lenke)
• Tone Bjørge; Christel Häggström; Sara Ghaderi et al. (2019). BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study. (ekstern lenke)
• Britton Trabert; Rebecca Troisi; Tom Grotmol et al. (2019). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. (ekstern lenke)
• Saed Safiri; Sadaf G. Sepanlou; Kevin S. Ikuta et al. (2019). The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. (ekstern lenke)
• Renate Graue; Stefan Lönnberg; Gry Baadstrand Skare et al. (2019). Atypical glandular lesions of the cervix and risk of cervical cancer. (ekstern lenke)
• Christel Häggström; Håkan Jonsson; Tone Bjørge et al. (2019). Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. (ekstern lenke)
• Josef Fritz; Tone Bjørge; Gabriele Nagel et al. (2019). The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. (ekstern lenke)
• Ann Kristin Knudsen; Peter Allebeck; Mette Christophersen Tollånes et al. (2019). Life expectancy and disease burden in the Nordic countries: results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. (ekstern lenke)
• Akram Pourshams; Sadaf G. Sepanlou; Kevin S. Ikuta et al. (2019). The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. (ekstern lenke)

2023

• Ming Sun; Josef Fritz; Christel Häggström et al. (2023). Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. (ekstern lenke)
• Amanda Ramos Da Cunha; Kelly Compton; Rixing Xu et al. (2023). The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Abira Paramsothy; Tor-Arne Hegvik; Anders Engeland et al. (2023). Fetal Exposure to Preeclampsia and Later Risk of Cardiometabolic Disorders: A Population-Based Cohort Study. (ekstern lenke)
• Josef Fritz; Sylvia H. J. Jochems; Tone Bjørge et al. (2023). Body mass index, triglyceride-glucose index, and prostate cancer death: a mediation analysis in eight European cohorts. (ekstern lenke)
• Camilla Kjellstadli; Rachel Bedenis Forster; Tor Åge Myklebust et al. (2023). Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study. (ekstern lenke)
• Jazmine Abril; Britton Trabert; Rebecca Troisi et al. (2023). Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case–control study. (ekstern lenke)
• Tone Bjørge; Vidar Hjellvik; Line Bjørge et al. (2023). Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study. (ekstern lenke)
• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2023). Cancer risk in the siblings of individuals with major birth defects: a large Nordic population-based case-control study. (ekstern lenke)

2004

• Synne Knopp; Tone Bjørge; Jahn M Nesland et al. (2004). p16(INK4a) and p21(Waf1/Cip1) expression correlates with clinical outcome in vulvar carcinomas. (ekstern lenke)
• Per Olaf Ekstrøm; Tone Bjørge; Anne Dørum et al. (2004). Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis. (ekstern lenke)
• T Luostarinen; T Lethinen; T Bjørge et al. (2004). Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. (ekstern lenke)
• T. Bjørge; A. Engeland; Tapio Luostarinen et al. (2004). Corrigendum. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. (ekstern lenke)
• Tapio Luostarinen; Matti Lehtinen; Tone Bjørge et al. (2004). Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri. (ekstern lenke)
• Tone Bjørge; Kathrine Lie; Eivind Hovig et al. (2004). BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study. (ekstern lenke)
• Anders Engeland; Tone Bjørge; A. Tverdal et al. (2004). Obesity in adolescence and adulthood and the risk of adult mortality. (ekstern lenke)

2022

• Sina Rostami; Hilde Langseth; robert lyle et al. (2022). Pre-diagnostic circulating RNAs in endometrial cancer – impact of body mass index. (ekstern lenke)
• Rajesh Sharma; Mohsen Abbasi-Kangevari; Rami Abd-Rabu et al. (2022). Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Rachel Bedenis Forster; Anders Engeland; Rune Kvåle et al. (2022). Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer. (ekstern lenke)
• Tone Bjørge; Birgit Øvstebø Engesæter; Gry Baadstrand Skare et al. (2022). CervicalScreen Norway – A screening programme in transition. (ekstern lenke)
• Rachel Bedenis Forster; Camilla Kjellstadli; Tor Åge Myklebust et al. (2022). Treatment and 30-Day Mortality after Myocardial Infarction in Prostate Cancer Patients: A Population-Based Study from Norway. (ekstern lenke)
• Rebecca Troisi; Ingrid Glimelius; Tom Grotmol et al. (2022). The role of pregnancy in maternal cancer risk: Epidemiologic evidence from the Nordic Countries Linked Birth and Cancer Registries Cohort Project. (ekstern lenke)
• Stefanos Tyrovolas; Andy Stergachis; Varsha Sarah Krish et al. (2022). Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. (ekstern lenke)
• Cari M. Kitahara; Dagrun Slettebø Daltveit; Anders Ekbom et al. (2022). Maternal Health, Pregnancy and Offspring Factors, and Maternal Thyroid Cancer Risk: A Nordic Population-Based Registry Study. (ekstern lenke)
• Ming Sun; Tone Bjørge; Stanley Teleka et al. (2022). Interaction of leisure-time physical activity with body mass index on the risk of obesity-related cancers: A pooled study. (ekstern lenke)
• Dagrun Slettebø Daltveit; Tone Bjørge; Kari Klungsøyr et al. (2022). Childhood cancer risk among children with major birth defects – sex differences?. (ekstern lenke)
• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2022). Cancer risk in individuals with siblings with major birth defects: A large Nordic population-based case-control study. (ekstern lenke)
• Khanh Bao Tran; Justin J. Lang; Kelly Compton et al. (2022). The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Benjamin Matthew Clarsen; Magne Nylenna; Søren Toksvig Klitkou et al. (2022). Changes in life expectancy and disease burden in Norway, 1990–2019: an analysis of the Global Burden of Disease Study 2019. (ekstern lenke)
• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2022). Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study. (ekstern lenke)
• Gunvor Aasbø; Ameli Trope; Mari Nygård et al. (2022). HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial. (ekstern lenke)

2020

• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2020). Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. (ekstern lenke)
• Dagrun Slettebø Daltveit; Anders Engeland; Kari Klungsøyr et al. (2020). Medfødte misdannelser gir økt risiko for kreft. (ekstern lenke)
• Camilla Sköld; Tone Bjørge; Anders Ekbom et al. (2020). Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. (ekstern lenke)
• Haidong Wang; Kaja M. Abbas; Mitra Abbasifard et al. (2020). Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Trude Gildestad; Tone Bjørge; Øystein Ariansen Haaland et al. (2020). Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway, 1999–2013. (ekstern lenke)
• Christopher J L Murray; GBD 2019 Viewpoint Collaborators; Adnan Kisa et al. (2020). Five insights from the Global Burden of Disease Study 2019. (ekstern lenke)
• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2020). Cancer risk in individuals with major birth defects: A large Nordic population-based case-control study among children, adolescents, and adults. (ekstern lenke)
• Cari M Kitahara; Dagrun Daltveit Slettebø; Anders Ekbom et al. (2020). Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. (ekstern lenke)
• Anne Gulbech Ording; Lotte Brix Christensen; Tone Bjørge et al. (2020). Birthweight and all-cause mortality after childhood and adolescent leukemia: a cohort of children with leukemia from Denmark, Norway, Sweden, and Washington State. (ekstern lenke)
• Farin Kamangar; Dariush Nasrollahzadeh; Saeid Safiri et al. (2020). The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. (ekstern lenke)
• Arash Etemadi; Saeid Safiri; Sadaf G. Sepanlou et al. (2020). The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017. (ekstern lenke)
• Dana Kristjansson; Birgit Øvstebø Engesæter; Gry Baadstrand Skare et al. (2020). Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening. (ekstern lenke)

2008

• Tone Bjørge; Sven Cnattingius; Rolv Terje Lie et al. (2008). Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. (ekstern lenke)
• Tone Bjørge; Anders Engeland; S Tretli et al. (2008). Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. (ekstern lenke)
• Tone Bjørge; Anders Engeland; Aage Tverdal et al. (2008). Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. (ekstern lenke)

2002

• T. Bjørge; Anders Engeland (2002). Bruk av p-piller og risiko for kreft. (ekstern lenke)
• T. Bjørge; Vera M Abeler; Kolbein Sundfør et al. (2002). Gestational trophoblastic tumors in Norway, 1968-1997: Patient characteristics, treatment and prognosis. (ekstern lenke)
• T. Bjørge; Vera M Abeler; Claes Gøran Trope et al. (2002). Trofoblast tumorer i Norge 1968-97. Pasientkarakteristika, behandling og prognose. (ekstern lenke)
• T. Bjørge; Anders Engeland; Tapio Luostarinen et al. (2002). Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. (ekstern lenke)

2010

• Jorunn Kirkeleit; Trond Riise; Tone Bjørge et al. (2010). Increased risk of oesophageal adenocarcinoma among upstream petroleum workers. (ekstern lenke)
• Anne Tandberg; Tone Bjørge; Ottar Nygård et al. (2010). Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies. (ekstern lenke)
• Tanja Stocks; Wegene Borena; Borena Wegene et al. (2010). Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). (ekstern lenke)
• Bente Kristin Johansen; Tone Bjørge (2010). Parodisk personvern. (ekstern lenke)
• Tone Bjørge; Annekatrin Lukanova; Håkan Jonsson et al. (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. (ekstern lenke)
• Dorthe Johansen; Tanja Stocks; Håkan Jonsson et al. (2010). Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. (ekstern lenke)
• Tone Bjørge; Tanja Stocks; Annekatrin Lukanova et al. (2010). Metabolic syndrome and endometrial carcinoma. (ekstern lenke)

2006

• Synne Knopp; Ruth Holm; Tone Bjørge et al. (2006). Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases. (ekstern lenke)
• Anders Engeland; Steinar Tretli; Lars Andreas Akslen et al. (2006). Body size and thyroid cancer in two million Norwegian men and women. (ekstern lenke)
• Tone Bjørge; Steinar Tretli; Agnes kathrine Lie et al. (2006). The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. (ekstern lenke)
• Synne Knopp; Ruth Holm; Tone Bjørge et al. (2006). Cell cycle regulation in primary vulvar carcinomas and related lymph node metastases. (ekstern lenke)

2012

• Hanno Ulmer; Tone Bjørge; Hans Concin et al. (2012). Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). (ekstern lenke)
• Sara Ghaderi; Rolv T. Lie; Dag Moster et al. (2012). Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway. (ekstern lenke)
• Gabriele Nagel; Tone Bjørge; Hans Concin et al. (2012). Metabolic syndrome and cervical cancer in the Metabolic Syndrome and Cancer Project (Me-Can). (ekstern lenke)
• Tor Haldorsen; Gry Baastrand Skare; Tone Bjørge et al. (2012). HPV-evalueringen – så rettferdig som mulig. (ekstern lenke)
• Michael Edlinger; Susanne Strohmaier; Håkan Jonsson et al. (2012). Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. (ekstern lenke)
• Gabriele Nagel; Tone Bjørge; Jonas Manjer et al. (2012). Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). (ekstern lenke)
• Tanja Stocks; Mieke Van Hemelrijck; Jonas Manjer et al. (2012). Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and cancer project. (ekstern lenke)
• Christel Häggström; Tanja Stocks; David Ulmert et al. (2012). Prospective study on metabolic factors and risk of prostate cancer. (ekstern lenke)
• Wegene Borena; Susanne Strohmaier; Annekatrin Lukanova et al. (2012). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. (ekstern lenke)
• Tone Bjørge (2012). Årstabeller for Medisinsk fødselsregister 2010 Fødsler i Norge. (ekstern lenke)
• Gabriele Nagel; Tanja Stocks; Daniela Späth et al. (2012). Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). (ekstern lenke)

2021

• Jonathan M. Kocarnik; Kelly Compton; Frances E. Dean et al. (2021). Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 A Systematic Analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Saeid Safiri; Ali-Asghar Kolahi; Mohsen Naghavi et al. (2021). Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease study 2019. (ekstern lenke)
• CM Kitahara; Tone Bjørge; Tom Grotmol et al. (2021). Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring – Authors’ reply. (ekstern lenke)
• Angela M. Wood; Håkan Jonsson; Gabriele Nagel et al. (2021). The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking. (ekstern lenke)
• Dagrun Slettebø Daltveit; Kari Klungsøyr; Anders Engeland et al. (2021). Childhood cancer risk among individuals with major birth defects: A Nordic collaborative study. (ekstern lenke)
• Anders Engeland; Sara Ghaderi; Isabel dos-Santos-Silva et al. (2021). Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study. (ekstern lenke)
• Gabriele Nagel; Tone Bjørge; Andrea Jaensch et al. (2021). Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project. (ekstern lenke)
• Hedyeh Ebrahimi; Zahra Aryan; Sahar Saeedi Moghaddam et al. (2021). Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. (ekstern lenke)
• Ingrid Baasland; Signe Opdahl; Tone Bjørge et al. (2021). Long-term risk of progression following CIN1. (ekstern lenke)
• Brit Helene Gravdal; Stefan Lönnberg; Gry Baadstrand Skare et al. (2021). Cervical cancer in women under 30 years of age in Norway: a population-based cohort study. (ekstern lenke)
• Elysia M Alvarez; Lisa M. Force; Rixing Xu et al. (2021). The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. (ekstern lenke)

2007

• A Tandberg; Tone Bjørge; Rolv Skjærven (2007). Twinning and triplet rates in Norway, 1967-2004. (ekstern lenke)
• Tone Bjørge; Anders Engeland; Steinar Tretli et al. (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. (ekstern lenke)
• Tone Bjørge (2007). Medfødte misdannelser og kreft, felles årsaksbakgrunn?. (ekstern lenke)
• Anne Tandberg; Tone Bjørge; Per E Børdahl et al. (2007). Increasing twinning rates in Norway, 1967-2004: the influence of maternal age and assisted reproductive technology (ART). (ekstern lenke)
• Anders Engeland; Steinar Tretli; Svein Hansen et al. (2007). Height and body mass index and risk of lymphohematopoietic malignancies in two million norwegian men and women. (ekstern lenke)

1998

• T. Bjørge; Anders Engeland; S.W. Hansen et al. (1998). Ovarialcancer og borderlinetumorer. (ekstern lenke)
• T. Bjørge; Anders Engeland; Kolbein Sundfør et al. (1998). Prognosis of 2.800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. (ekstern lenke)
• T. Bjørge; Anders Engeland; S.W. Hansen et al. (1998). Prognosis of patients with Ovarian Cancer and Borderline Tumours Diagnosed in Norway between 1954 and 1993. (ekstern lenke)
• T. Bjørge; Anders Engeland; S.W. Hansen et al. (1998). Ovarialcancer og borderlinetumorer. (ekstern lenke)

2003

• Anders Engeland; Steinar Tretli; T. Bjørge (2003). Height, body mass index and prostate cancer: a follow-up of 950 000 Norwegian men. (ekstern lenke)
• Anders Engeland; Steinar Tretli; T. Bjørge (2003). Height, body mass index and ovarian cancer: a follow-up of 1.1 million Norwegian women. (ekstern lenke)

2013

• Elisabeth Berge Budal; Hans Kristian Haugland; Robert Skar et al. (2013). HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway. (ekstern lenke)
• Haakon E Meyer; Trude Eid Robsahm; Tone Bjørge et al. (2013). Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. (ekstern lenke)
• Sara Wiren; Christel Häggström; Hanno Ulmer et al. (2013). Pooled cohort study on height and risk of cancer and cancer death. (ekstern lenke)
• Sara Ghaderi; Rolv T. Lie; Dag Moster et al. (2013). Erratum to: Cancer in childhood, adolescence, and young adults: a population-based study of changes in risk of cancer death during four decades in Norway. (ekstern lenke)
• Tone Bjørge; Henrik Toft Sørensen; Tom Grotmol et al. (2013). Fetal growth and childhood cancer: A population-based study. (ekstern lenke)
• Björn Lindkvist; Martin Almquist; Tone Bjørge et al. (2013). Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). (ekstern lenke)
• Anders Engeland; Tone Bjørge; Anne Kjersti Daltveit et al. (2013). Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. (ekstern lenke)
• S Strohmaier; M Edlinger; J Manjer et al. (2013). Total serum cholesterol and cancer incidence in the Metabolic Syndrome and Cancer Project (Me-Can). (ekstern lenke)
• Christel Häggström; Kilian Rapp; Tanja Stocks et al. (2013). Metabolic Factors Associated with Risk of Renal Cell Carcinoma. (ekstern lenke)
• Sara Ghaderi; Anders Engeland; Dag Moster et al. (2013). Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. (ekstern lenke)
• Stefan De Vogel; Klaus Meyer; Åse Fredriksen et al. (2013). Serum folate and vitamin B12 concentrations in relation to prostate cancer risk-a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort. (ekstern lenke)
• Jorunn Kirkeleit; Trond Riise; Tone Bjørge et al. (2013). The Healthy Worker Effect in Cancer Incidence Studies. (ekstern lenke)

1999

• T. Bjørge; Claes Gøran Trope; Anders Engeland (1999). Screening mot kreft. (ekstern lenke)
• Tapio Luostarinen; V. af Geijersstam; T. Bjørge et al. (1999). No excess risk of cervical carcinoma among women seropositive for both HPV 16 and HPV 6/11. (ekstern lenke)

2017

• Maria Winther Gunnes; Rolv T. Lie; Tone Bjørge et al. (2017). Suicide and violent deaths in survivors of cancer in childhood, adolescence and young adulthood-a national cohort study. (ekstern lenke)
• Kirsti Lund Vik; Randi Elin Gislefoss; Steinar Tretli et al. (2017). Cohort Profile Update: The Janus Serum Bank Cohort in Norway. (ekstern lenke)
• Agnes Kathrine Lie; Ameli Trope; Gry Baadstrand Skare et al. (2017). HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia. (ekstern lenke)
• Anders Engeland; Tone Bjørge; Kari Klungsøyr et al. (2017). Preterm births and use of medication in early adulthood: a population-based registry study. (ekstern lenke)

1996

• T. Bjørge; Øystein Kravdal (1996). Reproductive factors and prognosis of uterine cervical cancer in Norway. (ekstern lenke)
• T. Bjørge; Øystein Kravdal (1996). Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.

10 utvalgte publikasjoner

1. Daltveit DS, Klungsøyr K, Engeland A, Ekbom A, Gissler M, Glimelius I, Grotmol T, Madanat-Harjuoja L, Ording AG, Sørensen HT, Troisi R, Bjørge T. Sex differences in childhood cancer risk among children with major birth defects: a Nordic population-based nested case-control study. Int J Epidemiol 2023; 52: 450-65. (IF 9.7)

2. Sun M, Fritz J, Häggström C, Bjørge T, Nagel G, Manjer J, Engeland A, Zitt E, van Guelpen B, Stattin P, Ulmer H, Stocks T. Metabolically healthy and unhealthy obesity and risk of obesity-related cancers; a pooled study. JNCI 2023; 115: 456-67. (IF 11.8)

3. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2022; 400: 563-91. (IF 202.7)

4. Kitahara CM, Daltveit DS, Ekbom A, Engeland A, Gissler M, Glimelius I, Grotmol T, Lagerros YT, Madanat-Harjuoja L, Männistö T, Sørensen HT, Troisi R, Bjørge T. Maternal health, in utero and perinatal exposures, and risk of thyroid cancer in offspring a Nordic population-based nested case-control study. Lancet Diabetes Endocrinol 2021; 9: 94-105. (IF 44.9)

5. Daltveit DS, Klungsøyr K, Engeland A, Ekbom A, Gissler M, Glimelius I, Grotmol T, Madanat-Harjuoja L, Ording AG, Sæther SMM, Sørensen HT, Troisi R, Bjørge T. Cancer risk in individuals with major birth defects: A large Nordic population-based case-control study among children, adolescents and adults. BMJ 2020; 371: m4060. (IF 96.2)

6. Bjørge T, Häggström C, Ghaderi S, Nagel G, Manjer J, Tretli S, Ulmer H, Harlid S, Rosendahl AH, Lang A, Stattin P, Stocks T, Engeland A. BMI and weight changes and risk of obesity-related cancers: A pooled European cohort study. Int J Epidemiol 2019; 48: 1872-85. (IF 9.7)

7. Stocks T, Bjørge T, Ulmer H, Manjer J, Häggström C, Nagel G, Engeland A, Johansen D, Hallmans G, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 2015; 44: 1353-63. (IF 9.7)

8. Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can): Analysis of six prospective cohorts. PLoS Med 2009; 6 (12): e1000201. (IF 11.6)

9. Engeland A, Tretli S, Bjørge T. Height, body mass index, and ovarian cancer - a follow-up of 1,1 million Norwegian women. J Natl Cancer Inst 2003; 95: 1244-8. (IF 11.8)

10. Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315: 646-9. (IF 96.2)

 

Publikasjonsliste (fra CRIStin)

Forbedret prognose til pasienter med glioblastom (GlioLink prosjektet)

Forhold under graviditet og fødselskarakteristika i relasjon til kreft blant mor og barn

Metabolsk syndrom og kreft (Me-Can prosjektet)

Medisinbruk blant kreftoverlevere

Lege, spesialist i patologi

Dr. med. i kreftepidemiologi